Atomoxetine Increases Histamine Release and Improves Learning Deficits in an Animal Model of Attention‐Deficit Hyperactivity Disorder: The Spontaneously Hypertensive Rat

Basic and Clinical Pharmacology and Toxicology - Tập 102 Số 6 - Trang 527-532 - 2008
Lili Liu1, Jie Yang1, Gefei Lei1, Gongming Wang1, Yuwei Wang1, Ruopeng Sun1
1Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, China

Tóm tắt

Abstract:  Substantial development in the pharmacological treatment for attention‐deficit hyperactivity disorder (ADHD) has been made recently including approval of new non‐stimulant agents targeting noradrenergic, histaminergic and dopaminergic systems. Among such, atomoxetine has been widely used, although its mechanism of action is poorly understood. It is known that central nervous system histamine is closely associated with cognition and it was recently shown that both atomoxetine and methylphenidate enhance cortical histamine release in rats. To that end, the aim of our study was to investigate the effect of atomoxetine (2 mg/kg, intraperitoneally) on histamine release using the microdialysis technique in the spontaneously hypertensive rat (SHR), a suitable genetic model for ADHD. Our data confirmed that atomoxetine increases extracellular levels of histamine in the prefrontal cortex, a brain region that is implicated in the pathophysiology of ADHD. Given the tie between histamine neurotransmission and treatment of cognitive dysfunction, we also assessed the effects of atomoxetine on learning and memory as measured by the Morris water maze in SHR. The results indicated that atomoxetine significantly ameliorated performance in the Morris water maze, consistent with its histamine‐enhancing profile. In conclusion, the current study provides further support for the notion that the therapeutic effect of atomoxetine could involve activation of histamine neurotransmission within the prefrontal cortex.

Từ khóa


Tài liệu tham khảo

10.1016/S0959-4388(98)80150-5

10.1016/j.biopsych.2004.10.020

10.1080/09297040500205579

10.1016/S0149-7634(99)00058-5

10.1016/S0166-4328(01)00425-9

10.1017/S1461145705005341

10.1016/S0197-4580(00)00132-9

10.1016/S1074-7427(03)00024-8

10.1016/0166-4328(95)00165-4

10.1037/h0077649

10.1038/nrn896

10.1523/JNEUROSCI.18-15-05901.1998

10.1016/S0166-4328(01)00431-4

10.1016/S0149-7634(99)00062-7

10.1016/S0304-3940(00)01040-5

10.1097/00004583-199603000-00006

10.1016/S0166-4328(01)00421-1

10.1016/j.biopsych.2006.04.022

10.1016/S0166-4328(01)00379-5

10.1016/j.neubiorev.2004.09.006

10.1001/archpsyc.1996.01830050084013

10.1523/JNEUROSCI.22-19-08771.2002

Arnsten AF, 2006, Fundamentals of attention‐deficit/hyperactivity disorder: circuits and pathways, J Clin Psychiatry, 67, 7

10.1016/j.pharmthera.2004.05.001

10.1155/NP.2004.133

10.1038/nrn1034

10.1016/j.neures.2006.10.020

10.1517/13543784.14.3.223

10.1038/nrd1631

10.1016/j.ejphar.2006.11.048

10.1007/s002130050551

10.1016/S0893-133X(00)00119-6

Paxinos G, 1997, The Rat Brain in Stereotaxic Coordinates

10.1016/S0031-9384(99)00162-6

10.1002/syn.10043

10.1016/S0893-133X(02)00346-9

10.1016/j.neuropharm.2005.11.022

10.1016/j.neubiorev.2003.08.010

10.1016/S0301-0082(00)00039-3

Ligneau X, 1998, Neurochemical and behavioral effects of ciproxifan, a potent histamine H3‐receptor antagonist, J Pharmacol Exp Ther, 287, 658

10.1007/PL00005200

10.1016/S0149-7634(99)00053-6

10.1016/S0028-3908(00)00101-5

10.1111/j.1460-9568.2001.01361.x

10.1046/j.1460-9568.2003.02975.x

10.1111/j.1460-9568.2006.05046.x

10.1345/aph.1G582

10.1016/j.biopsych.2006.03.066

Thông tin
Thông tin xuất bản

Basic and Clinical Pharmacology and Toxicology

Tập 102 Số 6

527-532

Thông tin tác giả